Evaluating the Impact of a Positive Health Dialogue Tool in Veterans With PTSD: A Randomised Controlled Trial
EIPHDT
2 other identifiers
interventional
44
1 country
1
Brief Summary
The primary outcome is quality of life, with secondary outcomes including PTSD symptoms, and psychosocial functioning. We hypothesise that a low-dose intervention based on empowerment and self-directed goal setting will lead to (a) measurable improvements in veterans' quality of life and (b) reduced PTSD symptoms, and improved psychosocial functioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedFirst Submitted
Initial submission to the registry
December 3, 2025
CompletedFirst Posted
Study publicly available on registry
December 16, 2025
CompletedDecember 16, 2025
December 1, 2025
3.8 years
December 3, 2025
December 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Quality of Life Scores from Baseline, 6 Months, and 12 Months as Measured by the MANSA Questionnaire
From enrollment to 12 months post-enrollment
Secondary Outcomes (2)
Change in PTSD Symptom Severity from Baseline, 6 Months, and 12 Months as Measured by the PCL-5 Questionnaire
rom enrollment to 12 months post-enrollment
Change in Psychosocial Functioning from Baseline, 6 Months, and 12 Months as Measured by the TRACK 2.0 Questionnaire
From enrollment to 12 months post-enrollment
Study Arms (2)
Intervention group
EXPERIMENTALPositive Health dialogue tool
Control group
NO INTERVENTIONInterventions
This intervention is distinguished by the integration of a structured dialogue tool in two additional sessions, designed to enhance therapeutic engagement and reflection. Unlike standard trauma-focused therapy alone, this approach offers a unique combination of conventional treatment with a targeted communication strategy tailored to veterans with PTSD.
Eligibility Criteria
You may qualify if:
- A formal PTSD diagnosis
- At the start of treatment
- Aged 18 until 64
- Reading, writing, and speaking Dutch
You may not qualify if:
- Alcohol or drug dependency
- Severe cognitive impairments (e.g., dementia)
- Acute suicide risk, as assessed during the intake procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Reinier van Arkel, Psychotraumacentrum Zuid-Nederland
's-Hertogenbosch, North Brabant, 5211LJ, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Drs.
Study Record Dates
First Submitted
December 3, 2025
First Posted
December 16, 2025
Study Start
December 1, 2020
Primary Completion
September 1, 2024
Study Completion
September 1, 2025
Last Updated
December 16, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
The datasets generated during and/or analysed during the current study will be stored in a nonpublicly available repository en will be available upon request from the corresponding author.